| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |